Islay Capital Management’s AtriCure ATRC Stock Holding History

Islay Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,783	Closed	-$117K	–	279
2022 Q1	$117K	Buy	+1,783	New	+$116K	0.1%	131

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Islay Capital Management's ATRC Position: Q2 2022 in Review

Islay Capital Management sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 1,783 shares — an estimated $117K sold.

Islay Capital Management first reported a position in ATRC in Q1 2022 and held it in 1 quarter. The position peaked at $117K in Q1 2022. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

Islay Capital Management reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
Islay Capital Management sold 1,783 AtriCure shares in Q2 2022, an estimated $117K.
Islay Capital Management first reported a position in AtriCure in Q1 2022 and held it in 1 quarter.
Islay Capital Management's AtriCure position peaked at $117K in Q1 2022.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Islay Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.